GPP

Great Point Partners Portfolio holdings

AUM $240M
1-Year Est. Return 106.75%
This Quarter Est. Return
1 Year Est. Return
+106.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$154M
AUM Growth
-$30.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
37
New
Increased
Reduced
Closed

Top Buys

1
+$9.88M
2
+$9.81M
3
+$7.52M
4
AKRO icon
Akero Therapeutics
AKRO
+$5.54M
5
JBIO
Jade Biosciences
JBIO
+$4.98M

Top Sells

1
+$10.9M
2
+$10.1M
3
+$9.98M
4
KALV icon
KalVista Pharmaceuticals
KALV
+$7.81M
5
ASND icon
Ascendis Pharma
ASND
+$7.79M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBOT
26
BridgeBio Oncology
BBOT
$1.05B
$312K 0.2%
29,381
-344,452
DVAX icon
27
Dynavax Technologies
DVAX
$1.3B
– –
-595,879
MREO
28
Mereo BioPharma
MREO
$283M
– –
-1,275,000
MRUS icon
29
Merus
MRUS
$7.28B
– –
-237,156
PCVX icon
30
Vaxcyte
PCVX
$6.37B
– –
-115,517
ASND icon
31
Ascendis Pharma
ASND
$12.5B
– –
-50,000
AUTL
32
Autolus Therapeutics
AUTL
$365M
– –
-2,728,910
BEAM icon
33
Beam Therapeutics
BEAM
$2.2B
– –
-175,562
DNTH icon
34
Dianthus Therapeutics
DNTH
$1.75B
– –
-275,000
SMMT icon
35
Summit Therapeutics
SMMT
$13.4B
– –
0
VRDN icon
36
Viridian Therapeutics
VRDN
$2.74B
– –
-750,000
VYGR icon
37
Voyager Therapeutics
VYGR
$219M
– –
-626,275
1
2